Ind-Swift Laboratories (BOM:532305) Marketable Securities : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Ind-Swift Laboratories Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Ind-Swift Laboratories's Marketable Securities for the quarter that ended in Dec. 2024 was ₹0 Mil.

Ind-Swift Laboratories's annual Marketable Securities declined from Mar. 2022 (₹119 Mil) to Mar. 2023 (₹50 Mil) and declined from Mar. 2023 (₹50 Mil) to Mar. 2024 (₹0 Mil).

Ind-Swift Laboratories Marketable Securities Historical Data

The historical data trend for Ind-Swift Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories Marketable Securities Chart

Ind-Swift Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Marketable Securities

Get a 7-Day Free Trial

112.72

83.02

118.90

49.54

Ind-Swift Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

Ind-Swift Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Ind-Swift Laboratories (BOM:532305) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Ind-Swift Laboratories Marketable Securities Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ind-Swift Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (BOM:532305) » Definitions » Marketable Securities

Traded in Other Exchanges

INDSWFTLAB:India

Address

SCO 850, NAC, Shivalik Enclave, Manimajra, Chandigarh, PB, IND, 160101

Website

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd is engaged in the business of manufacturing Active Pharmaceutical Ingredients (API), Intermediates, and formulations. The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. It operates in a single segment namely, Bulk Drugs and Pharmaceuticals. Geographically, the company caters to both Indian and international markets, of which, maximum revenue is derived from outside India.

Ind-Swift Laboratories Headlines

No Headlines